INTRODUCTION. Joining forces for the replacement of animal studies in food sciences

Size: px
Start display at page:

Download "INTRODUCTION. Joining forces for the replacement of animal studies in food sciences"

Transcription

1 INTRODUCTION Joining forces for the replacement of animal studies in food sciences

2 Background - science Rapid advances in scientific knowledge e.g. genomics, exposure science Toxicology is moving away from whole-animal approaches to one based on mechanistic understanding Huge technological advances e.g. HTS, informatics, comp. tox.

3 Background - science Scientific value of animal studies being challenged Speed of innovation creating novel materials e.g. nano, biotechnology Too many chemicals not enough animals/money/time!

4 Background stakeholders Consumers Regulators Consumers are increasingly unwilling to accept animal testing for food safety/ nutrition In 1980s EU committed to replace AT 86/609/EEC development and validation of alternatives 2010/63/EU principles of 3Rs FDE Congress one of the most pressing priorities is alternatives to animal testing - there needs to be change in culture EFSA communicating a need for change in attitude to animal testing. Indicators of regulatory change - Cosmetic testing bans - EFSA review modern methodologies and tools (EFSA, 2014) - USFDA Redbook undergoing major review

5 THE DILEMMA A need for safety and nutritional decisions to be made on the basis of the best scientific approaches In this rapidly developing world the best science is not necessarily reliant on new data generated from animals

6 Regulatory & Scientific Inertia Often there may be a regulatory precedent for animal testing even though it may not be scientifically justified Scientific committees expect to see animal data even if there may not be a regulatory requirement

7 Important to Collaborate & Form Stakeholder Partnerships ACADEMIA CONSUMER TRUST GOVERNMENT /REGULATORS INDUSTRY

8 The Opportunity An emerging issue for Foods and Beverages ILSI Europe address this global challenge by initiating an activity that encompasses both safety and nutritional / efficacy issues surrounding animal testing and foods/ beverages

9 Alternatives to Animal Testing Task Force Objectives Communicate to stakeholders on the development of alternative strategies in this area. Review and assess the recently developed methods and provide evidence-based science on their potential use and limitation, and assess when these methods could ultimately replace animal testing. Build a global consensus on how and what is needed to reduce animal testing in food and beverage development

10 Expert Group Holistic Approaches to Develop Alternative Strategies to Animal Testing in Food Safety, Nutrition and Efficacy Studies Review the case for animal testing for foods from both a safety and nutritional/ efficacy perspective and when it can be avoided/ replaced. Communication to stakeholders alternative strategies peer reviewed publications, workshops.

11 Task Force: Alternatives to Animal Testing Task Force member Dr Paul Hepburn - Chair Dr Rocio Fernández Cantón Vice Chair Dr Cyrille Krul Co Chair Dr Markus Fehr Ms Caroline Perreau Dr Katrin Schütte Dr Sylvain Etter (member co-rep.) Dr Constanze Stiefel Dr Vassilis Triantis Dr Johanneke van der Harst Dr Jan van der Valk Dr Lucie Geurts Affiliation Unilever Monsanto Europe University of Applied Sciences DSM Roquette European Commission Firmenich WALA Heilmittel Friesland Campina Danone 3R-Centre Utrecht Life Sciences ILSI Europe

12 Expert Group: Holistic Approaches to Develop Alternative Strategies that do not rely on Additional Animal Testing Task Force member Affiliation Country Dr Vassilis Triantis - Chair Friesland Campina NL Dr Maria Tabernero Urbieta Vice Chair IMDEA Food ES Dr Markus Fehr DSM CH Ms Laura Caneva Monsanto Europe BE Dr Paul Hepburn Unilever UK Dr Nynke Kramer University Utrecht NL Dr Katrin Schütte European Commission BE Dr Johanneke van der Harst Danone NL Prof Koen Venema University of Maastricht NL Prof Bob van de Water Leiden University NL Dr Lucie Geurts ILSI Europe BE

13 Expert Group: Holistic Approaches to Develop Alternative Strategies that do not rely on Additional Animal Testing Objectives 1. Review food safety, efficacy and nutritional regulations and summarise these existing regulations 2. Develop an overview of the existing tools or methodologies that could be applied to food safety, nutrition and efficacy assessments and do not involve animal testing 3. Verify whether these tools and methodologies can be applied to the current regulations in food safety and nutrition. This project will thus identify existing tools and approaches which are not reliant on generating data in animals to address those requirements.

14 Upcoming Activities - Future Topics of Interest Dissemination/ peer reviewed publication New potential activities should be identified from the workshop Workshop holistic approaches (Sept 2018)

15 Upcoming Activities One ILSI Initiative One ILSI Interest from several ILSI branches Opportunity to leverage the project impact Build a global initiative International Workshop 2019 Aim: share worldwide and suggest some approaches

16 Manuscript Outline Introduction food safety testing Food supplements Food additives Food enzymes Food flavors Nutritional health claims Infant formulae Foods for special medical purposes Novel foods GMOs Tools and methodologies Conclusion

17

Welcome, Introduction and Objectives of the Workshop

Welcome, Introduction and Objectives of the Workshop Welcome, Introduction and Objectives of the Workshop Nutrition for the Ageing Brain: Towards Evidence for an Optimal Diet 3 July 2014 Prof. Diána Bánáti Executive and Scientific Director, ILSI Europe 1

More information

Future Outlook for ILSI Europe

Future Outlook for ILSI Europe Future Outlook for ILSI Europe Gert W. Meijer, PhD Vice-President Nutrition & Health, Member, BoD ILSI Europe 1 Declaration of Interest Full-time employee of Unilever NV Other assignments: Member of the

More information

Toward guidelines for maternal and infant nutrition to influence long-term health of the offspring: The past and future of ILSI Europe work on

Toward guidelines for maternal and infant nutrition to influence long-term health of the offspring: The past and future of ILSI Europe work on Toward guidelines for maternal and infant nutrition to influence long-term health of the offspring: The past and future of ILSI Europe work on metabolic imprinting Ricardo Rueda, MD PhD Abbott Nutrition

More information

SATIETY AND APPETITE CONTROL CLAIMS: GETTING IT RIGHT FOR CONSUMERS

SATIETY AND APPETITE CONTROL CLAIMS: GETTING IT RIGHT FOR CONSUMERS SATIETY AND APPETITE CONTROL CLAIMS: GETTING IT RIGHT FOR CONSUMERS Toine Hulshof, PhD Kellogg Europe (NL) Chairman Eating Behaviour and Energy Balance Task Force International Life Sciences Institute

More information

ILSI Europe Workshop on Assessing and Reporting Uncertainties in Dietary Exposure Analysis. Welcome and opening. Prof.

ILSI Europe Workshop on Assessing and Reporting Uncertainties in Dietary Exposure Analysis. Welcome and opening. Prof. ILSI Europe Workshop on Assessing and Reporting Uncertainties in Dietary Exposure Analysis 6 February 2014, Brussels, Belgium Welcome and opening Prof. Diána Bánáti Executive and Scientific Director, ILSI

More information

Science for All, All for Science Scientific Achievements of ILSI Europe

Science for All, All for Science Scientific Achievements of ILSI Europe Science for All, All for Science Scientific Achievements of ILSI Europe ILSI Europe 2013 Annual Symposium 26-27 March 2013, Brussels, Belgium Prof. Diána Bánati Executive and Scientific Director, ILSI

More information

ILSI Europe. The European branch of the International Life Sciences Institute. Aspects of Energy Metabolism. 10 May 2012, Lyon, France

ILSI Europe. The European branch of the International Life Sciences Institute. Aspects of Energy Metabolism. 10 May 2012, Lyon, France ILSI Europe The European branch of the International Life Sciences Institute Aspects of Energy Metabolism 10 May 2012, Lyon, France Dr Stephane Vidry 1 ILSI Mission To improve public health and safety

More information

Dutch Life Sciences November 24 th, Erik Dam, CBO

Dutch Life Sciences November 24 th, Erik Dam, CBO Dutch Life Sciences November 24 th, 2016 Erik Dam, CBO Unmet need for food ingredients with clinically proven health benefits Consumers want healthy foods and will pay more for them (Forbes 2015) Global

More information

Organization Main figures Member Companies Main Activities Focus on Collaborative Activities

Organization Main figures Member Companies Main Activities Focus on Collaborative Activities Organization Main figures Member Companies Main Activities Focus on Collaborative Activities ILSI BRASIL - ORGANIZATION COMMUNICATION Progress from 2001-2011 60 50 40 30 20 10 2001 2002 2003 2004 2005

More information

SAFETY EVALUATION OF FOODS: NOVEL INGREDIENTS & ADDITIVES

SAFETY EVALUATION OF FOODS: NOVEL INGREDIENTS & ADDITIVES SAFETY EVALUATION OF FOODS: NOVEL INGREDIENTS & ADDITIVES Paul Hepburn, PhD Director Food Safety Safety & Environmental Assurance Centre Unilever UK 1 SAFETY & ENVIRONMENTAL ASSURANCE CENTRE (SEAC) PROTECTING

More information

Dietary Sweetness A Controversy

Dietary Sweetness A Controversy Dietary Sweetness A Controversy Prof. Diána Bánáti Executive and Scientific Director ILSI Europe Hits Google Scholar Hits for Taste Perception" OR "Sweetness Perception" 2000 1800 1600 1400 1200 1000 800

More information

Threshold of Toxicological Concern Overview of Ongoing Scientific Developments

Threshold of Toxicological Concern Overview of Ongoing Scientific Developments Threshold of Toxicological Concern Overview of Ongoing Scientific Developments TTC threshold of toxicological concern derives a limit value (thresholds) below which a lifetime risk for human health is

More information

ANNUAL DECLARATION OF INTERESTS (ADoI)

ANNUAL DECLARATION OF INTERESTS (ADoI) ANNUAL DECLARATION OF INTERESTS (ADoI) (Please note that high quality of scientific expertise is by nature based on prior experience and that therefore having an interest does not necessarily mean having

More information

Pain and Palliative care in the European Commission s Framework Programmes. European Commission Research DG Dr. Elengo Manoussaki

Pain and Palliative care in the European Commission s Framework Programmes. European Commission Research DG Dr. Elengo Manoussaki Pain and Palliative care in the European Commission s Framework Programmes European Commission Research DG Dr. Elengo Manoussaki European Parliament resolution on combating cancer in the enlarged EU Calls

More information

Update FDA/Center for Food Safety and Applied Nutrition

Update FDA/Center for Food Safety and Applied Nutrition Update FDA/Center for Food Safety and Applied Nutrition Comments by Susan Mayne, Ph.D. Director Center for Food Safety and Applied Nutrition FDLI Annual Conference May 3, 2018 Food Safety, Nutrition and

More information

E-RARE & THE EUROPEAN JOINT PROGRAMME ON RARE DISEASES. RE(ACT) 2018 Congress 7-10 of March 2018 Bologna, ITALY

E-RARE & THE EUROPEAN JOINT PROGRAMME ON RARE DISEASES. RE(ACT) 2018 Congress 7-10 of March 2018 Bologna, ITALY E-RARE & THE EUROPEAN JOINT PROGRAMME ON RARE DISEASES RE(ACT) 2018 Congress 7-10 of March 2018 Bologna, ITALY E-RARE THE ERA-NET FOR RESEARCH PROGRAMMES ON RARE DISEASES MAJOR FACTS ABOUT E-RARE ERA-NET

More information

Food Labeling: Policy Rationale IFT Food Policy Impact, 2011

Food Labeling: Policy Rationale IFT Food Policy Impact, 2011 Food Labeling: Policy Rationale IFT Food Policy Impact, 2011 Barbara O. Schneeman, Ph.D. Office of Nutrition, Labeling and Dietary Supplements CFSAN-FDA General Labeling Provisions FDA s authority to regulate

More information

JOSEFIEN VENDRIK, QUALITY MANAGER IRENE JONGENELEN, COÖRDINATOR CLINICAL SUPPLIES MANAGEMENT/ SENIOR CLINICAL STUDY MANAGER

JOSEFIEN VENDRIK, QUALITY MANAGER IRENE JONGENELEN, COÖRDINATOR CLINICAL SUPPLIES MANAGEMENT/ SENIOR CLINICAL STUDY MANAGER Food for Thought JOSEFIEN VENDRIK, QUALITY MANAGER IRENE JONGENELEN, COÖRDINATOR CLINICAL SUPPLIES MANAGEMENT/ SENIOR CLINICAL STUDY MANAGER CLINOPS DAG, 12 APRIL 2018 HISTORY OF RESEARCH AND DEVELOPMENT

More information

GUIDEA Guidance for Dietary Intake and Exposure Assessment A New Resource for Exposure Assessment Professionals

GUIDEA Guidance for Dietary Intake and Exposure Assessment A New Resource for Exposure Assessment Professionals Food and Nutrition Sciences, 2013, 4, 315-320 http://dx.doi.org/10.4236/fns.2013.43042 Published Online March 2013 (http://www.scirp.org/journal/fns) GUIDEA Guidance for Dietary Intake and Exposure Assessment

More information

ILSI LATIN AMERICAN BRANCHES MEETING ILSI ANNUAL MEETING 2012 January 24, 2012 Phoenix, Arizona

ILSI LATIN AMERICAN BRANCHES MEETING ILSI ANNUAL MEETING 2012 January 24, 2012 Phoenix, Arizona ILSI LATIN AMERICAN BRANCHES MEETING ILSI ANNUAL MEETING 2012 January 24, 2012 Phoenix, Arizona ILSI North Andean Branch: 1997 2012/15 th Anniversary Supporting the region Colombia Ecuador Venezuela We

More information

Food Allergen Thresholds & Probabilistic Risk Assessment: Current State of the Science. Joe Baumert, Ph.D.

Food Allergen Thresholds & Probabilistic Risk Assessment: Current State of the Science. Joe Baumert, Ph.D. Food Allergen Thresholds & Probabilistic Risk Assessment: Current State of the Science Joe Baumert, Ph.D. Food Allergy Research & Resource Program Department of Food Science & Technology University of

More information

Global Regulation of Food Additives

Global Regulation of Food Additives Chapter 1 Global Regulation of Food Additives Downloaded via 148.251.232.83 on January 28, 2019 at 18:43:58 (UTC). See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published

More information

EFSA Statement regarding the EU assessment of glyphosate and the socalled

EFSA Statement regarding the EU assessment of glyphosate and the socalled EFSA Statement regarding the EU assessment of glyphosate and the socalled Monsanto papers Background On 29 May 2017, EFSA received a request from the European Commission to produce a statement concerning

More information

Uncertainties in Dietary Exposure Analysis A Challenge to Be Addressed

Uncertainties in Dietary Exposure Analysis A Challenge to Be Addressed Uncertainties in Dietary Exposure Analysis A Challenge to Be Addressed Dr David Tennant Food Chemical Risk Analysis, UK Conflict of interest regarding this presentation: I wish to declare a potential conflict

More information

ILSI SEA Region 10th Seminar on Nutrition Labeling, Claims and Communication Strategies, August 28-29, 2018, KL, Malaysia

ILSI SEA Region 10th Seminar on Nutrition Labeling, Claims and Communication Strategies, August 28-29, 2018, KL, Malaysia ILSI SEA Region 10th Seminar on Nutrition Labeling, Claims and Communication Strategies, August 28-29, 2018, KL, alaysia 10th Seminar on Harmonization of Nutrition Labeling, Nutrition and Health Claims:

More information

Joint Programming Initiative on Neurodegenerative Diseases. Prof. Philippe Amouyel Chair, JPND Management Board

Joint Programming Initiative on Neurodegenerative Diseases. Prof. Philippe Amouyel Chair, JPND Management Board Joint Programming Initiative on Neurodegenerative Diseases Prof. Philippe Amouyel Chair, JPND Management Board Cases / 100 Alzheimer s disease in Europe 40 Number of cases Societal costs ( ) 2010 6,000,000

More information

STRATEGIC PLAN

STRATEGIC PLAN STRATEGIC PLAN 2016 2020 Promoting and supporting excellence in research www.immunology.org BSI STRATEGY 2016 2020 EXECUTIVE SUMMARY OUR MISSION Our mission is to promote excellence in immunological research,

More information

Harmonized Salt Iodization future policy approach to achieve the mission and vision in eliminating Iodine deficiency in Europe

Harmonized Salt Iodization future policy approach to achieve the mission and vision in eliminating Iodine deficiency in Europe Harmonized Salt Iodization future policy approach to achieve the mission and vision in eliminating Iodine deficiency in Europe Introduction Brussels, 01.11.2017 The joint WHO and UNICEF report published

More information

View on Existing Models, Applicability and Limitations: Public Health Perspective

View on Existing Models, Applicability and Limitations: Public Health Perspective The European Commission s science and knowledge service Joint Research Centre View on Existing Models, Applicability and Limitations: Public Health Perspective Jan Wollgast ILSI Europe Workshop Identifying

More information

PROTECT Alcohol labelling policies to protect young people

PROTECT Alcohol labelling policies to protect young people PROTECT Alcohol labelling policies to protect young people EAHC 25 January 2010 Workshop on Best Practice Models 1 PROTECT: Alcohol labelling policies to protect young people Partners: CRIOC: coordinator

More information

ILSI Europe session programme

ILSI Europe session programme programme Food Consumption and Public Health SESSION PROGRAMME Chair : Prof. Martine Laville CRNH-RA, France Co-chair: Dr. Stéphane Vidry, ILSI Europe, Belgium 11.00-11.05 Introduction to ILSI Europe Dr.

More information

Revision of the CIOMS ethical guidelines for Biomedical Research

Revision of the CIOMS ethical guidelines for Biomedical Research Revision of the CIOMS ethical guidelines for Biomedical Research Prof dr JJM van Delden MD PhD Professor of medical ethics, UMC Utrecht, NL Chair revision WG CIOMS j.j.m.vandelden@umcutrecht.nl What is

More information

Federation of EU Specialty Food Ingredients Industries

Federation of EU Specialty Food Ingredients Industries Federation of EU Specialty Food Ingredients Industries Additives: - Discovering the new EU positive lists of food additives and preparing for EFSA s re-evaluation system - Getting ready for a changing

More information

METHODOLOGIES FOR INTERMITTENT AND SHORT-TERM EXPOSURE TO CARCINOGENS SUBCOMMITTEE

METHODOLOGIES FOR INTERMITTENT AND SHORT-TERM EXPOSURE TO CARCINOGENS SUBCOMMITTEE METHODOLOGIES FOR INTERMITTENT AND SHORT-TERM EXPOSURE TO CARCINOGENS SUBCOMMITTEE Mission The mission of the MISTEC Subcommittee is to develop methodologies for establishing appropriate dose-metrics to

More information

MENTAL HEALTH AND WELLNESS OUTCOME OF THE TOWN HALL

MENTAL HEALTH AND WELLNESS OUTCOME OF THE TOWN HALL 2017 2019 MENTAL HEALTH AND WELLNESS OUTCOME OF THE TOWN HALL INTRODUCTION The University of Guelph has committed to improving wellness of students, staff, and faculty on campus. In 2016, the University

More information

Medical Devices and the Public s Health: The FDA 510(k) Clearance Process at 35 Years. Written Statement of

Medical Devices and the Public s Health: The FDA 510(k) Clearance Process at 35 Years. Written Statement of Medical Devices and the Public s Health: The FDA 510(k) Clearance Process at 35 Years Written Statement of Dr. David R. Challoner Vice President for Health Affairs, Emeritus University of Florida and Chair,

More information

Spreading Excellence and Widening Participation

Spreading Excellence and Widening Participation Spreading Excellence and Widening Participation Dr G Ambroziewicz Ankara, 27/02/2017 Research and Background Disparities in research and innovation performance: barrier to competitiveness, growth and jobs

More information

Future of Diabetes Research in Europe JDRF Perspective

Future of Diabetes Research in Europe JDRF Perspective Future of Diabetes Research in Europe JDRF Perspective IMI-JDRF Diabetes Patient Meeting 20 May 2014 Brussels, Belgium Olivier ARNAUD, Pharm D JDRF European Research Director oarnaud@jdrf.org Future of

More information

The European Food Safety Summit

The European Food Safety Summit The European Food Safety Summit The European Food Safety Summit, which was organised on 22nd November 2007 by EFSA jointly with the Portuguese Presidency and the European Commission, was a highlight of

More information

DEMENTIA: IMPLEMENTATION REPORT AND CURRENT DEVELOPMENTS EU HEALTH

DEMENTIA: IMPLEMENTATION REPORT AND CURRENT DEVELOPMENTS EU HEALTH DEMENTIA: IMPLEMENTATION REPORT AND CURRENT DEVELOPMENTS EU HEALTH Brussels, 19 March 2015 Michael Hübel Programme Management and Diseases Directorate-General for Health and Food Safety European Commission

More information

EUPATI beyond January 2017 Nicola Bedlington and the EUPATI Team

EUPATI beyond January 2017 Nicola Bedlington and the EUPATI Team EUPATI beyond January 2017 Nicola Bedlington and the EUPATI Team The EUPATI journey so far what have we achieved after 5 years? A trusted and credible public-private partnership between patient organisations,

More information

BDA IMPROVING ONCOLOGY DRUG DEVELOPMENT FOR CHILDREN AND ADOLESCENTS NOVEMBER 2013 WORKSHOP ADVANCE PROGRAMME

BDA IMPROVING ONCOLOGY DRUG DEVELOPMENT FOR CHILDREN AND ADOLESCENTS NOVEMBER 2013 WORKSHOP ADVANCE PROGRAMME BDA WORKSHOP IMPROVING ONCOLOGY DRUG DEVELOPMENT FOR CHILDREN AND ADOLESCENTS 18-19 NOVEMBER 2013 PARIS, FRANCE BIOTHERAPY DEVELOPMENT ASSOCIATION encca European Network for Cancer Research in Children

More information

Cancer Research in the EU Framework Programmes for RTD

Cancer Research in the EU Framework Programmes for RTD Cancer Research in the EU Framework Programmes for RTD Action against cancer: European platform Maria Vidal, MD, PhD Deputy Head of Unit Medical and public health research Health Directorate DG Research

More information

RD-ACTION DISSEMINATION PLAN TABLE I - STAKEHOLDER ANALYSIS

RD-ACTION DISSEMINATION PLAN TABLE I - STAKEHOLDER ANALYSIS RD-ACTION DISSEMINATION PLAN TABLE I - STAKEHOLDER ANALYSIS Stakeholder Group Interest in RD-Action Dissemination purpose Channels of Dissemination (WHO) (WHY) (WHY) (HOW) Partners of RD-Action & members

More information

Progress from the Patient-Centered Outcomes Research Institute (PCORI)

Progress from the Patient-Centered Outcomes Research Institute (PCORI) Progress from the Patient-Centered Outcomes Research Institute (PCORI) Anne Beal, Chief Operating Officer of the Patient-Centered Outcomes Research Institute Sharon-Lise Normand, Vice Chair, Methodology

More information

A multi-stakeholder partnership initiative. 10 February 2012

A multi-stakeholder partnership initiative. 10 February 2012 A multi-stakeholder partnership initiative 10 February 2012 1 History 39 recommendations on stakeholder actions and public policies:» 8 addressing regulatory barriers in rare cancer care» 11 addressing

More information

2009/SOM2/SCSC/WKSP2/014

2009/SOM2/SCSC/WKSP2/014 2009/SOM2/SCSC/WKSP2/014 Modernizing and Harmonizing Infant Formula and Medical Foods Nutrient Methods - Risk Management Perspective: A Stakeholder Approach for Establishing International Consensus Standards

More information

Summary Report EU Health Award 2017

Summary Report EU Health Award 2017 EPSA Vaccination Awareness Public Health Campaign 2016 Summary Report EU Health Award 2017 1. Introduction & Case Situation Background With WHO European Vaccine Action Plan 2015-2020 being developed and

More information

The Pharmacy Quality Alliance Optimizing Health by Advancing the Quality of Medication Use

The Pharmacy Quality Alliance Optimizing Health by Advancing the Quality of Medication Use Optimizing Health by Improving the Quality of Medication Use Adult Immunization Measure Development Update The Optimizing Health by Advancing the Quality of Medication Use Lisa Hines, PharmD Senior Director,

More information

Protecting the unborn baby from alcohol. Brief Summary

Protecting the unborn baby from alcohol. Brief Summary Protecting the unborn baby from alcohol 17 th September 2013 European Parliament, Brussels Brief Summary October 2013 Organised by: Hosted by: With the support of: 17 Rue Archimede I 1000 Brussels I Belgium

More information

Background EVM. FAO/WHO technical workshop on nutrient risk assessment, Geneva, May 2005, published 2006.

Background EVM. FAO/WHO technical workshop on nutrient risk assessment, Geneva, May 2005, published 2006. UK GOVERNMENT RESPONSE TO THE EUROPEAN COMMISSION S DISCUSSION PAPER ON THE SETTING OF MAXIMUM AND MINIMUM AMOUNTS FOR VITAMINS AND MINERALS IN FOODSTUFFS. Background The United Kingdom (UK) Government

More information

International Conference On Role Of Diet, Physical Activity & Lifestyle In Promoting Health

International Conference On Role Of Diet, Physical Activity & Lifestyle In Promoting Health International Conference On Role Of Diet, Physical Activity & Lifestyle In Promoting Health 20-21 November 2015 Hotel Taj Samudra, Colombo, Sri Lanka, Agenda Organized By International Life Sciences Institute-South

More information

First Phase of Impact Assessment on Endocrine Disruptors:

First Phase of Impact Assessment on Endocrine Disruptors: First Phase of Impact Assessment on Endocrine Disruptors: How to screen which chemicals would fall under different options for criteria to identify endocrine disruptors EU Conference on Endocrine Disruptors,

More information

Evaluation of new technology-based tools for dietary intake assessment

Evaluation of new technology-based tools for dietary intake assessment Evaluation of new technology-based tools for dietary intake assessment Alison Eldridge, PhD, RD Nestlé Research Center, Lausanne On behalf of the ILSI Europe Expert Group Evaluation of new methods for

More information

Positive Media Messages on Health and Diet for Parents and Children

Positive Media Messages on Health and Diet for Parents and Children Positive Media Messages on Health and Diet for Parents and Children 17 February 2006 Life Skills Workshop European Platform for Action on Diet, Physical Activity and Health Who is Reed Elsevier? Reed Elsevier

More information

Food Packaging: A Matter of Food Safety

Food Packaging: A Matter of Food Safety 6 th International Food Packaging Symposium Food Packaging: A Matter of Food Safety Prof. Diána Bánáti Executive and Scientific Director ILSI Europe Food packaging through history For ages, conservation

More information

Putting thresholds into practice: where are we now?

Putting thresholds into practice: where are we now? Putting thresholds into practice: where are we now? Anaphylaxis Campaign Corporate Members Conference, The Brewery, London Allergen Thresholds: the complete picture René Crevel René Crevel Consulting Limited

More information

Conflict of Interest Disclosure

Conflict of Interest Disclosure Conflict of Interest Disclosure I wish to declare a potential conflict of interest, and that I have received direct industry support from the International Life Sciences Institute (ILSI) in relation to

More information

Foreword. Our shared principles

Foreword. Our shared principles Our Digital Future Foreword The way we manage our lives is changing. 86% of households now have internet access, 82% of people go online every day and 72% of adults use a smartphone 1. It is now time to

More information

Parkinson s Research Program

Parkinson s Research Program Parkinson s Research Program Strategic Plan INTRODUCTION The Congressionally Directed Medical Research Programs (CDMRP) represents a unique partnership among the U.S. Congress, the military, and the public

More information

COOPERATION FOR INCREASED SCIENTIFIC CAPACITY

COOPERATION FOR INCREASED SCIENTIFIC CAPACITY COOPERATION FOR INCREASED SCIENTIFIC CAPACITY Guilhem de Seze Head of Scientific Evaluation of Regulated Products Department, European Food Safety Authority (EFSA) Japan International Conference, 25-26

More information

CUMULATIVE AND AGGREGATED EXPOSURE TO PESTICIDES (ACROPOLIS PROJECT)

CUMULATIVE AND AGGREGATED EXPOSURE TO PESTICIDES (ACROPOLIS PROJECT) CUMULATIVE AND AGGREGATED EXPOSURE TO PESTICIDES (ACROPOLIS PROJECT) Partners: RIVM, FERA, University of Milan, CRD, IRAS, INRAN, NIPH, DLO, NFA, Freshfel Europe and University of Ghent Associated partners:

More information

Update on the NCI Cancer Centers Program Henry P. Ciolino, Ph.D. Director, Office of Cancer Centers

Update on the NCI Cancer Centers Program Henry P. Ciolino, Ph.D. Director, Office of Cancer Centers Update on the NCI Cancer Centers Program Henry P. Ciolino, Ph.D. Director, Office of Cancer Centers April 30, 2017 History of the CCSG Funding Opportunity Announcement What hasn t changed What has changed

More information

50 YEARS CODEX ALIMENTARIUS SAFE, GOOD FOOD FOR EVERYONE

50 YEARS CODEX ALIMENTARIUS SAFE, GOOD FOOD FOR EVERYONE THE CODEX ALIMENTARIUS COMMISSION: CELEBRATING 50 YEARS OF THE CAC Codex Committee on Methods of Analysis and Sampling Budapest, Hungary 5.3.2013 Mrs Awilo Ochieng Pernet Vice-Chairperson, Codex Alimentarius

More information

WORKABLE REGULATORY FRAMEWORK EUROPEAN PARLIAMENT, BRUSSELS 9 NOVEMBER 2016

WORKABLE REGULATORY FRAMEWORK EUROPEAN PARLIAMENT, BRUSSELS 9 NOVEMBER 2016 SPEECH 9 November 2016 BOTANICAL FOOD SUPPLEMENTS: TOWARDS A WORKABLE REGULATORY FRAMEWORK EUROPEAN PARLIAMENT, BRUSSELS 9 NOVEMBER 2016 Check against delivery. Ladies and Gentlemen, Honourable Mr Arimont,

More information

The science behind labeling issues and health claims a European perspective

The science behind labeling issues and health claims a European perspective 2005 CSL/JIFSAN Joint Symposium on Food Safety and Nutrition: Bioactive Food Components The science behind labeling issues and health claims a European perspective Dr Michele Kellerhals Scientific and

More information

MEETING PROSPECTUS. International Workshop on NASH Biomarkers

MEETING PROSPECTUS. International Workshop on NASH Biomarkers International Workshop on NASH Biomarkers 2018 18-19 May 2018 Washington, D.C., USA MEETING PROSPECTUS www.expertmedicaleducation.com www.expertmedicalevents.com ADVANCING HEALTH GLOBALLY THROUGH INNOVATIVE

More information

DuPont Nutrition & Health Craig Binetti, President

DuPont Nutrition & Health Craig Binetti, President Craig Binetti, President Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this

More information

authorisation of nutrition & health claims Scientific substantiation of health claims Role of the European Food Safety Authority

authorisation of nutrition & health claims Scientific substantiation of health claims Role of the European Food Safety Authority Second Congress on Food Supplements The Scientific Substantiation of Health Claims Professor David P. Richardson DPR Nutrition Ltd, UK 11 th December 2009 Belgrade OUTLINE The scope, classification and

More information

Industry Perspective on Patient Preference Information

Industry Perspective on Patient Preference Information Industry Perspective on Patient Preference Information FDA/CERSI PPI Workshop November 7, 2017 Bennett Levitan, MD-PhD Benefit-Risk Team Lead Department of Epidemiology Janssen Research & Development,

More information

Problems of alcohol and drug use Working group session

Problems of alcohol and drug use Working group session Problems of alcohol and drug use Working group session The session was chaired by Vivian Barnekow Rasmussen, Technical Adviser for Promotion of Young People's Health within the WHO Regional Office for

More information

TRDRP Tobacco Policy Research Centers 2018 Call for Applications. Applicant Informational Webinar

TRDRP Tobacco Policy Research Centers 2018 Call for Applications. Applicant Informational Webinar TRDRP Tobacco Policy Research Centers 2018 Call for Applications Applicant Informational Webinar December 7, 2017 2 Outline TRDRP overview and mission Tobacco Policy Centers: Calendar Purpose and Focus

More information

WCO ACTION PLAN FOR THE ECONOMIC COMPETITIVENESS PACKAGE

WCO ACTION PLAN FOR THE ECONOMIC COMPETITIVENESS PACKAGE WCO ACTION PLAN FOR THE ECONOMIC COMPETITIVENESS PACKAGE Overview The Economic Competitiveness Package (ECP) was endorsed at the 119 th /120 th Sessions of the WCO Council, with three core goals : (1)

More information

ENHANCEMENTS OF THE INTERNATIONAL LIFE SCIENCES INSTITUTE CROP COMPOSITION DATABASE (

ENHANCEMENTS OF THE INTERNATIONAL LIFE SCIENCES INSTITUTE CROP COMPOSITION DATABASE ( ENHANCEMENTS OF THE INTERNATIONAL LIFE SCIENCES INSTITUTE CROP COMPOSITION DATABASE (www.cropcomposition.org) R.D.Shillito, W.P.Ridley, M.Levine Raymond D. Shillito, Ph.D. Bayer CropScience LP Chair, ILSI

More information

The EU PIP - a step in Pediatric Drug Development. Thomas Severin Bonn,

The EU PIP - a step in Pediatric Drug Development. Thomas Severin Bonn, The EU PIP - a step in Pediatric Drug Development Thomas Severin Bonn, 13.01.2009 Agenda Implications for Industry Company Preparation Time of PIP Submission Content of the PIP The PIP Process and first

More information

A Blueprint for Breast Cancer Deadline 2020

A Blueprint for Breast Cancer Deadline 2020 A Blueprint for Breast Cancer Deadline 2020 In 1991, the National Breast Cancer Coalition was formed with one mission: an end to breast cancer. NBCC has accomplished much over its twenty plus years: bringing

More information

European Food Safety Authority (EFSA)

European Food Safety Authority (EFSA) TECHNICAL REPORT APPROVED: 06 April 2017 doi:10.2903/sp.efsa.2017.en-1210 Outcome of the preliminary pesticides peer review meeting on the assessment of endocrine disrupting properties in mammalian toxicology

More information

Workshop for OIE national Focal Points for Veterinary Products November 2010, Johannesburg, South Africa. Presentation

Workshop for OIE national Focal Points for Veterinary Products November 2010, Johannesburg, South Africa. Presentation Dr. Anja Holm Chair of CVMP, EMA Danish Medicines Agency Copenhagen, DK - Denmark anh@dkma.dk Overview of existing structures relevant for Veterinary Products Regional Structures: Europe European Medicine

More information

NCRI Biomarkers & Imaging CSG Cell-free DNA workshop

NCRI Biomarkers & Imaging CSG Cell-free DNA workshop NCRI Biomarkers & Imaging CSG Cell-free DNA workshop Workshop Report Christie Education Centre, Manchester 30th January 2014 Sponsored by Workshop summary 86 delegates from a variety of specialities attended

More information

Compiling your dossier - what the EFSA guidance doesn t tell you

Compiling your dossier - what the EFSA guidance doesn t tell you 1 Compiling your dossier - what the EFSA guidance doesn t tell you Stoffer Loman, PhD NutriClaim Innovation in Sports Nutrition Workshop Sports Nutrition Health Claims London, 29-30 May, 2012 NutriClaim

More information

ECIBC overview. Donata LERDA Healthcare Quality Team leader

ECIBC overview. Donata LERDA Healthcare Quality Team leader ECIBC overview Donata LERDA Healthcare Quality Team leader Joint Research Centre Institute for Health and Consumer Protection Public Health Policy Support Disclaimer: The contents of this presentation

More information

1. Welcome from the President Chris Thompson, the outgoing ISAD President opened the AGM and welcomed the participants.

1. Welcome from the President Chris Thompson, the outgoing ISAD President opened the AGM and welcomed the participants. International Society for Affective Disorders Annual General Meeting 6 th March 2006. Alfa Corinthia Hotel, Lisbon, Portugal Minutes Record of Attendees Kay Wilhelm Gustavo Vasquez Roumen Milev Steven

More information

On the occasion of World Digestive Health Day 2013: The importance of research into liver cancer and alcohol as a risk factor

On the occasion of World Digestive Health Day 2013: The importance of research into liver cancer and alcohol as a risk factor On the occasion of World Digestive Health Day 2013: The importance of research into liver cancer and alcohol as a risk factor Introduction On May 29 2013 EASL and UEG organised the event The importance

More information

SIXTEENTH MEETING OF THE HIGH LEVEL GROUP ON NUTRITION AND PHYSICAL ACTIVITY. CHAIR: Despina Spanou. Final Minutes

SIXTEENTH MEETING OF THE HIGH LEVEL GROUP ON NUTRITION AND PHYSICAL ACTIVITY. CHAIR: Despina Spanou. Final Minutes SIXTEENTH MEETING OF THE HIGH LEVEL GROUP ON NUTRITION AND PHYSICAL ACTIVITY 15 th NOVEMBER 2012 10.00-16.00 VENUE: CHARLEMAGNE BUILDING [ROOM: JENKINS] CHAIR: Despina Spanou Final Minutes 1. INTRODUCTION

More information

DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014

DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014 DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014 Karen Arts, Director Canadian Cancer Clinical Trial Network (3CTN) Chair of the Board of N2 Administrative Office: Lawson

More information

JPI A healthy diet for a healthy life. JPI: concept and benefits Vision Research areas Governance

JPI A healthy diet for a healthy life. JPI: concept and benefits Vision Research areas Governance JPI A healthy diet for a healthy life JPI: concept and benefits Vision Research areas Governance European research area Today, 85% of public R&D is programmed, financed, monitored and evaluated at national

More information

Developing Program Logic Models B.E.S.T. Collaboration in LA County

Developing Program Logic Models B.E.S.T. Collaboration in LA County Developing Program Logic Models B.E.S.T. Collaboration in LA County SRM Evaluation Group UCLA Graduate School of Education & Information Studies Department of Education, Division of Social Research Methodology

More information

A global strategy to reduce the harmful use of alcohol

A global strategy to reduce the harmful use of alcohol A global strategy to reduce the harmful use of alcohol Endorsed by the World Health Assembly in May 2010 Global strategy to reduce the harmful use of alcohol Developed through a long and intense collaboration

More information

COMPENDIUM OF MONOGRAPHS NATURAL HEALTH PRODUCTS DIRECTORATE

COMPENDIUM OF MONOGRAPHS NATURAL HEALTH PRODUCTS DIRECTORATE COMPENDIUM OF MONOGRAPHS NATURAL HEALTH PRODUCTS DIRECTORATE June 13 2013 Version 3.0 i FOREWORD Guidance documents are meant to provide assistance to industry and health care practitioners on how to comply

More information

Accelerating the Pace of Chemical Risk Assessments

Accelerating the Pace of Chemical Risk Assessments Accelerating the Pace of Chemical Risk Assessments An International Workshop Hosted by the US EPA September 14-15, 2016 in Washington DC Robert Kavlock, US EPA European Commission Scientific Conference

More information

MS Priority Setting Partnership. PROTOCOL August 2012

MS Priority Setting Partnership. PROTOCOL August 2012 MS Priority Setting Partnership PROTOCOL August 2012 Purpose The purpose of this protocol is to set out the aims, objectives and commitments of the MS Priority Setting Partnership (PSP) and the basic roles

More information

The Codex Alimentarius

The Codex Alimentarius The Codex Alimentarius Herman B.W.M. Koëter, MSc, DTox, ERT Managing Director and Executive Secretary of the Management Board,, vzw Codex Alimentarius A joint WHO/FAO Food Standards Programme; 171 member

More information

European Commission Initiative on Breast Cancer. Annual Declaration of Interests (ADoI)

European Commission Initiative on Breast Cancer. Annual Declaration of Interests (ADoI) European Commission Initiative on Breast Cancer Annual Declaration of Interests (ADoI) Name: Mireille BROEDERS [Please copy rows as needed for subsequent or parallel activities of the same nature] [If

More information

Common Criteria for Cosmetic Claims

Common Criteria for Cosmetic Claims Common Criteria for Cosmetic Claims Job done or the opening of Pandora s Box? Dr Chris Flower Director-General Cosmetic, Toiletry and Perfumery Association www.ctpa.org.uk Presentation summary: CAP/BCAP

More information

Commissioner Margrethe Vestager, European Commission Rue de la Loi 170, 1049 Brussels

Commissioner Margrethe Vestager, European Commission Rue de la Loi 170, 1049 Brussels Commissioner Margrethe Vestager, European Commission Rue de la Loi 170, 1049 Brussels Open letter from the Association of European Cancer Leagues Task Force on Equal Access to Cancer Medicines and the

More information

You will have responsibility for:

You will have responsibility for: Public Engagement Officer UKRI NERC BGS Lyell Centre, Edinburgh 30,357-32,997 (depending on qualifications and experience) Full Time 37 hours a week (a range of flexible working options may be available)

More information

Chronic Diseases/Maternal & Child Health Michigan Department of Community Health, Lifecourse Epidemiology and Genomics Division

Chronic Diseases/Maternal & Child Health Michigan Department of Community Health, Lifecourse Epidemiology and Genomics Division Chronic Diseases/Maternal & Child Health Michigan Department of Community Health, Lifecourse Epidemiology and Genomics Division Lansing, MI Assignment Description The Fellow will be working with mentors

More information

Jayna Holroyd-Leduc, MD, FRCPC Associate Professor, Section of Geriatrics, U of Calgary Co-Chair of TVN s Citizen Engagement Initiative

Jayna Holroyd-Leduc, MD, FRCPC Associate Professor, Section of Geriatrics, U of Calgary Co-Chair of TVN s Citizen Engagement Initiative Jayna Holroyd-Leduc, MD, FRCPC Associate Professor, Section of Geriatrics, U of Calgary Co-Chair of TVN s Citizen Engagement Initiative Giving Voice to Frail Elderly Canadians Initiative Led by members

More information

ACTIVITIES IN 2011 D H PAI PANANDIKER, CHAIRMAN

ACTIVITIES IN 2011 D H PAI PANANDIKER, CHAIRMAN ACTIVITIES IN 2011 D H PAI PANANDIKER, CHAIRMAN OFFICE BEARERS OF ILSI-INDIA Mr. D H Pai Panandiker, Chariman Mr. N M Kejriwal, President Mr. Sunil Adsule, Treasurer Executive Director Ms. Rekha Sinha

More information

Risk Monitor How-to guide

Risk Monitor How-to guide Risk Monitor How-to guide Contents INTRODUCTION... 3 RESEARCH METHODS... 4 THE RISK MONITOR... 5 STEP-BY-STEP GUIDE... 6 Definitions... 7 PHASE ONE STUDY PLANNING... 8 Define the target population... 8

More information